alexa
Reach Us +44-1647-403003
N-myc Downstream Regulated Gene (NDRG): Role in Cancer Metastasis Suppression and as Drug Target in Cancer Therapeutics | OMICS International | Abstract
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

N-myc Downstream Regulated Gene (NDRG): Role in Cancer Metastasis Suppression and as Drug Target in Cancer Therapeutics

Bekesho Geleta1*, Eyasu Makonnen2 and Solomon M Abay2

1Directorate of Traditional and Modern Medicine Research, Ethiopian Public Health Institute, Addis Ababa, Ethiopia

2Department of Pharmacology, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia

Corresponding Author:
Geleta B
Directorate of Traditional and Modern Medicine Research
Ethiopian Public Health Institute, Addis Ababa, Ethiopia
Tel: 01121334 99
E-mail: mailto:[email protected]

Received Date: May 12, 2016; Accepted Date: June 24, 2016; Published Date: June 27, 2016

Citation: Geleta B, Makonnen E, Abay SM (2016) N-myc Downstream Regulated Gene (NDRG): Role in Cancer Metastasis Suppression and as Drug Target in Cancer Therapeutics. J Cancer Sci Ther 8:154-159. doi:10.4172/1948-5956.1000407

Copyright: © 2016 Geleta B, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

N-myc downstream regulated gene (NDRG) is, a ubiquitously expressed, a family of cytosolic proteins consists of four members, NDRG1-4. It plays and important role in cancer such as aberrant expression, tumor suppressive, metastatic suppressive and oncogenic functions. In this review, we comprehensively present the expression as well as the clinical and pathological significance of NDRG in human cancers. NDRG1 one of NDRG family which is a ubiquitously expressed protein localized in different tissues of the body, especially breast. It may act as a central regulator of multiple signaling pathways that modulate tumor progression. NDRG2 is expressed in brain, gastric, pancreatic and prostate cells. NDRG3 is highly expressed in testis, prostate, muscle and ovary. Whereas, NDRG4 is highly expressed in brain, hear and colorectal cells. NDRG is down-regulated and associated with the incidence, progression and prognosis of diverse cancers. It is associated with tumor incidence, progression, and metastasis. NDRG has low expression in cancer patients, whereas, inducement of NDRG activity has metastatic suppression effect and also increased in apoptotic effect through increased p53 activity. Metastasis is the spread of a cancer from one organ or part of the body to another not directly connected with it. NDRG is negatively correlated with tumor progression in multiple neoplasms, being a promising new target for cancer treatment. Hence, a drug that has a capacity to enhance an activity of NDRG has a potential to be considered as anti-metastatic agent.

Keywords

Share This Page
Top